| Severe COVID-19 is marked by a dysregulated myeloid cell compartment J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ... Cell, 2020 | 1312 | 2020 |
| COVID-19 and the human innate immune system JL Schultze, AC Aschenbrenner Cell 184 (7), 1671-1692, 2021 | 669 | 2021 |
| Swarm Learning for decentralized and confidential clinical machine learning S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ... Nature, 1-7, 2021 | 623 | 2021 |
| FOXO-dependent regulation of innate immune homeostasis T Becker, G Loch, M Beyer, I Zinke, AC Aschenbrenner, P Carrera, ... Nature 463 (7279), 369-373, 2010 | 393 | 2010 |
| SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ... Cell 184 (26), 6243-6261. e27, 2021 | 328 | 2021 |
| Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19 JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ... Immunity 53 (6), 1296-1314. e9, 2020 | 309 | 2020 |
| Neutrophils in COVID-19 N Reusch, E De Domenico, L Bonaguro, J Schulte-Schrepping, K Baßler, ... Frontiers in immunology 12, 652470, 2021 | 284 | 2021 |
| Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients AC Aschenbrenner, M Mouktaroudi, B Kraemer, M Oestreich, ... Genome Medicine 13 (1), 1-25, 2021 | 236 | 2021 |
| Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19 B Krämer, R Knoll, L Bonaguro, M ToVinh, J Raabe, ... Immunity, 2021 | 179 | 2021 |
| The myeloid cell compartment—cell by cell K Bassler, J Schulte-Schrepping, S Warnat-Herresthal, ... Annual review of immunology 37 (1), 269-293, 2019 | 176 | 2019 |
| Cellular Differentiation of Human Monocytes Is Regulated by Time-Dependent Interleukin-4 Signaling and the Transcriptional Regulator NCOR2 J Sander, SV Schmidt, B Cirovic, N McGovern, O Papantonopoulou, ... Immunity 47 (6), 1051-1066. e12, 2017 | 164 | 2017 |
| Complement activation induces excessive T cell cytotoxicity in severe COVID-19 P Georg, R Astaburuaga-García, L Bonaguro, S Brumhard, L Michalick, ... Cell 185 (3), 493-512. e25, 2022 | 154 | 2022 |
| Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76 MS Jordan, JE Smith, JC Burns, JET Austin, KE Nichols, ... Immunity 28 (3), 359-369, 2008 | 122 | 2008 |
| Dysregulated functions of lung macrophage populations in COPD TS Kapellos, K Bassler, AC Aschenbrenner, W Fujii, JL Schultze Journal of Immunology Research 2018 (1), 2349045, 2018 | 74 | 2018 |
| Epigenetic reprogramming of immune cells in injury, repair, and resolution K Placek, JL Schultze, AC Aschenbrenner The Journal of clinical investigation 129 (8), 2994-3005, 2019 | 67 | 2019 |
| A guide to systems-level immunomics L Bonaguro, J Schulte-Schrepping, T Ulas, AC Aschenbrenner, M Beyer, ... Nature immunology 23 (10), 1412-1423, 2022 | 51 | 2022 |
| Urban living in healthy Tanzanians is associated with an inflammatory status driven by dietary and metabolic changes GS Temba, V Kullaya, T Pecht, BT Mmbaga, AC Aschenbrenner, T Ulas, ... Nature Immunology 22 (3), 287-300, 2021 | 46 | 2021 |
| Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics K Rabold, A Aschenbrenner, C Thiele, CK Boahen, A Schiltmans, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 45 | 2020 |
| Murine Creld1 controls cardiac development through activation of calcineurin/NFATc1 signaling E Mass, D Wachten, AC Aschenbrenner, A Voelzmann, M Hoch Developmental cell 28 (6), 711-726, 2014 | 36 | 2014 |
| Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes W Fujii, TS Kapellos, K Baßler, K Händler, L Holsten, R Knoll, ... ERJ open research 7 (3), 2021 | 31 | 2021 |
